Onconova Therapeutics, Inc. to Present Corporate Update at 2016 BIO Investor Forum
Oct 13, 2016 11:01 am UTC| Business
NEWTOWN, Pa., Oct. 13, 2016 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that...
Oct 13, 2016 11:01 am UTC| Business
FDA agrees that Overall Response Rate (ORR) data from revised GENUINE study can be used to request pre-BLA (Biologics License Application) meeting If results of the revised GENUINE study are positive, the Company plans...
FDA, CLINUVEL to Discuss SCENESSE® at Pre-NDA Meeting
Oct 13, 2016 11:01 am UTC| Business
MELBOURNE, Australia and NEW YORK, Oct. 13, 2016 -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (OTC:CLVLY) (XETRA:UR9)today announced that it will meet with the US Food and Drug Administration (FDA) on 7 November to...
Pluristem CEO Zami Aberman Re-Elected to Alliance for Regenerative Medicine’s Board of Directors
Oct 13, 2016 11:01 am UTC| Business
HAIFA, Israel, Oct. 13, 2016 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced its Chairman and CEO, Zami Aberman, has been re-elected...
Aptose Provides Update on FDA Clinical Hold of APTO-253
Oct 13, 2016 11:01 am UTC| Business
SAN DIEGO and TORONTO, Oct. 13, 2016 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...
RedHill Biopharma to Present at the BIO Investor Forum 2016
Oct 13, 2016 11:00 am UTC| Business
TEL-AVIV, Israel, Oct. 13, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...
Heat Biologics Remains on Track to Achieve Multiple Topline Data Readouts this Quarter
Oct 13, 2016 11:00 am UTC| Business
DURHAM, N.C., Oct. 13, 2016 -- Heat Biologics, Inc. (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that it continues to remain on...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects